Essentra Valuation
Is FLRA.F undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of FLRA.F when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: FLRA.F ($2) is trading below our estimate of fair value ($2.24)
Significantly Below Fair Value: FLRA.F is trading below fair value, but not by a significant amount.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for FLRA.F?
Key metric: As FLRA.F is barely profitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is FLRA.F's PS Ratio? | |
|---|---|
| PS Ratio | 1.4x |
| Sales | UK£309.70m |
| Market Cap | UK£430.37m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 1.7x |
| Enterprise Value/EBITDA | 13.2x |
| PEG Ratio | 327.5x |
Price to Sales Ratio vs Peers
How does FLRA.F's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 0.6x | ||
ASIX AdvanSix | 0.5x | 6.1% | US$846.8m |
WLKP Westlake Chemical Partners | 0.7x | 6.7% | US$823.5m |
SIRE Sisecam Resources | 0.7x | n/a | US$511.9m |
KOP Koppers Holdings | 0.4x | 1.8% | US$775.1m |
FLRA.F Essentra | 1.4x | 1.8% | US$430.4m |
Price-To-Sales vs Peers: FLRA.F is expensive based on its Price-To-Sales Ratio (1.4x) compared to the peer average (0.5x).
Price to Sales Ratio vs Industry
How does FLRA.F's PS Ratio compare vs other companies in the US Chemicals Industry?
Price-To-Sales vs Industry: FLRA.F is good value based on its Price-To-Sales Ratio (1.4x) compared to the US Chemicals industry average (1.4x).
Price to Sales Ratio vs Fair Ratio
What is FLRA.F's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 1.4x |
| Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate FLRA.F's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
Nippon Sanso Holdings
JP¥1.9t
Engages in the gas business in Japan, the United States, Europe, Asia, and Oceania.
TYNP.F
JP¥29.18
7D
-2.1%
1Y
6.2%
Ecora Resources
UK£162.5m
Operates as a natural resource royalty and streaming company in Australia, North and South America, Europe, and internationally.
ECRA.F
UK£0.82
7D
-3.5%
1Y
-29.3%
Allied Gold
CA$1.1b
Explores for and produces mineral deposits in Africa.
AAUC.F
CA$2.47
7D
6.5%
1Y
-13.2%